HIGH-AFFINITY CD20-SPECIFIC TCRS SUITABLE FOR ADOPTIVE IMMUNOTHERAPY CAN BE READILY ISOLATED FROM THE ALLO-REPERTOIRE USING REVERSE IMMUNOLOGY